<DOC>
	<DOCNO>NCT02979730</DOCNO>
	<brief_summary>The purpose study compare Emergency Department patient undergo influenza test use FDA-approved point-of-care device ( Cobas Liat Influenza A/B assay ) locate ED , patient whose sample send BMC central laboratory . Patients agree participate sample randomly assign test either core lab , POC device . The current turnaround time sample send laboratory approximately two hour ; investigator expect point care device reduce time . Investigators determine time disposition administration antibiotic different group undergo POC influenza test compare undergoing laboratory-based influenza test</brief_summary>
	<brief_title>Impact Rapid Flu Testing BMC ED</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Adult patient 21 year age old Presenting BMC main ED Urgent Care area influenzalike illness Physician order influenza A/B diagnostic test Previously enrol study Any Influenza test result already available time approach ED RA Physician order comprehensive multiplex PCR respiratory pathogen assay instead initial influenza A/Bonly test . Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>